COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics

This article is brought to you in association with the European Commission. The EU Strategy on COVID-19 Therapeutics delivers today its first outcome, with the announcement of the first portfolio of five therapeutics that could soon be available to treat patients across the EU. Four of these therapeutics are monoclonal antibodies under rolling review by the […]

Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics

This article is brought to you in association with the European Commission. The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, […]